Natalia A. Shushunova

Natalia A. Shushunova

Auto-generated profile, based on publicly available information

Natalia A. Shushunova

Science Medical Center, Saratov State University, 83 Astrakhanskaya Str., 410012 Saratov, Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2020 in IEEE Journal of Selected Topics in Quantum Electronics
Verified
Journal Article
Closed access
PDPolina A. Dyachenko
Polina A. Dyachenko
LDLeonid E. Dolotov
Leonid E. Dolotov
ELEkaterina Nikolaevna Lazareva
Ekaterina Nikolaevna Lazareva
AKAnastasia A. Kozlova
Anastasia A. Kozlova
OIOlga A. Inozemtseva
Olga A. Inozemtseva
VZVladimir P. Zharov
Vladimir P. Zharov
Most cancer deaths are associated with metastases resulting from the spread of circulating tumor cells (CTCs) from the primary tumor to vital organs. The existing methods for detection of CTCs as markers of metastasis progression are time consuming with several steps of sample processing, including red blood cell removal, labeling, immunomagnetic capture and isolation, which can lead to loss of CTCs. Here we introduce a method for detection and identification of CTCs using spectral absorption imaging of melanoma cells and optical clearing of whole blood samples. Verification of this approach was performed using phantoms of human melanoma cells and suspensions of mouse melanoma cells of line B16F10 alone and in mixture with blood. A method for improving detection sensitivity has been demonstrated applying optical clearing of mouse blood using biocompatible chemical agents. The findings suggest that the proposed diagnostic platform has the potential to detect quickly CTCs in whole blood samples from patients with melanoma.

14 May 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
OGOlga I. Gusliakova
Olga I. Gusliakova
EPEkaterina Prikhozhdenko
Ekaterina Prikhozhdenko
VPValentina O. Plastun
Valentina O. Plastun
OMOksana Mayorova
Oksana Mayorova
NSNatalia A. Shushunova
Natalia A. Shushunova
Olga SindeevaOlga Sindeeva
Olga Sindeeva
The problem of reducing the side effects associated with drug distribution throughout the body in the treatment of various kidney diseases can be solved by effective targeted drug delivery. The method described herein involves injection of a drug encapsulated in polyelectrolyte capsules to achieve prolonged local release and long-term capillary retention of several hours while these capsules are administered via the renal artery. The proposed method does not imply disruption (puncture) of the renal artery or aorta and is suitable for long-term chronic experiments on mice. In this study, we compared how capsule size and dosage affect the target kidney blood flow. It has been established that an increase in the diameter of microcapsules by 29% (from 3.1 to 4.0 μm) requires a decrease in their concentration by at least 50% with the same suspension volume. The photoacoustic method, along with laser speckle contrast imaging, was shown to be useful for monitoring blood flow and selecting a safe dose. Capsules contribute to a longer retention of a macromolecular substance in the target kidney compared to its free form due to mechanical retention in capillaries and slow impregnation into surrounding tissues during the first 1–3 h, which was shown by fluorescence tomography and microscopy. At the same time, the ability of capillaries to perform almost complete “self-cleaning” from capsular shells during the first 12 h leads to the preservation of organ tissues in a normal state. The proposed strategy, which combines endovascular surgery and the injection of polymer microcapsules containing the active substance, can be successfully used to treat a wide range of nephropathies.

29 July 2023 in Cytometry Part A
Verified
Journal Article
Closed access
OGOleg Grishin
Oleg Grishin
NSNatalia A. Shushunova
Natalia A. Shushunova
DBDaniil Bratashov
Daniil Bratashov
EPEkaterina Prikhozhdenko
Ekaterina Prikhozhdenko
RVRoman Verkhovskii
Roman Verkhovskii
Valery TuchinValery Tuchin
Valery Tuchin

5 November 2025 in Journal of Innovative Optical Health Sciences
Verified
Journal Article
Open access
YSY. Surkov
Y. Surkov
PTP. Timoshina
P. Timoshina
IUI. Uvakin
I. Uvakin
NSN. Shushunova
N. Shushunova
AKAnton Konovalov
Anton Konovalov
Valery TuchinValery Tuchin
Valery Tuchin
The clinical deployment of transcranial laser speckle-contrast imaging (LSCI) is limited by pronounced multiple scattering in cranial bone, which substantially reduces probing depth and distorts estimates of cerebral blood flow parameters. In this study, a hybrid strategy combining computational optical clearing (COC) with tartrazine-induced optical clearing of cranial bone is proposed and experimentally validated. Topical application of a 30% (w/v) tartrazine solution reduces the scattering coefficient of cranial bone from [ ] to [ ] [ ]mm[ ] by refractive index matching and by decreasing the intratissue heterogeneity of their spatial distribution. Residual quasi-static scattering components persisting after tartrazine-induced optical clearing are selectively removed by COC based on principal component analysis filtering, yielding an approximately twofold increase in vessel contrast-to-noise ratio (from 1.5 to 3.1) and exposing vascular networks invisible with conventional transcranial LSCI. This algorithm automatically ranks components in descending order of their contribution to the total variance: components with large eigenvalues correspond to quasi-static structures (cranial bone and stationary brain tissue), whereas those with small eigenvalues contain the dynamic signal arising from blood flow. Applying the Guttman–Kaiser criterion enables selective reconstruction of the dynamic component while suppressing background scattering. This synergistic approach opens new possibilities for noninvasive, high-contrast visualization of cerebral blood flow and represents a promising, qualitatively new direction in the development of physico-digital optical clearing technologies.

Verified
Journal Article
Open access
PDF file
NSNatalia A. Shushunova
Natalia A. Shushunova
OMOksana Mayorova
Oksana Mayorova
EPEkaterina Prikhozhdenko
Ekaterina Prikhozhdenko
OGOlga Goryacheva
Olga Goryacheva
OKOleg Alexandrovich Kulikov
Oleg Alexandrovich Kulikov
Olga SindeevaOlga Sindeeva
Olga Sindeeva
Complex immunosuppressive therapy is prescribed in medical practice to patients with glomerulonephritis to help them overcome symptoms and prevent chronic renal failure. Such an approach requires long-term systemic administration of strong medications, which causes severe side effects. This work shows the efficiency of polymer capsule accumulation (2.8 ± 0.4 µm) containing labeled etanercept (100 μg per dose) in the kidneys of mice. The comparison of injection into the renal artery and tail vein shows the significant superiority of the intra-arterial administration strategy. The etanercept retention rate of 18% and 8% ID in kidneys was found 1 min and 1 h after injection, respectively. The capsules were predominantly localized in the glomeruli after injection in mice using a model of acute glomerulonephritis. Histological analysis confirmed a significant therapeutic effect only in animals with intra-arterial administration of microcapsules with etanercept. The proposed strategy combines endovascular surgery and the use of polymer microcapsules containing a high molecular weight drug that can be successfully applied to treat a wide range of kidney diseases associated with glomerular pathology.

26 June 2024 in Journal of Biophotonics
Verified
Journal Article
Closed access
Elina A. GeninaElina A. Genina
Elina A. Genina
ELEkaterina Nikolaevna Lazareva
Ekaterina Nikolaevna Lazareva
YSYuri I. Surkov
Yuri I. Surkov
ISIsabella Anatolievna Serebryakova
Isabella Anatolievna Serebryakova
NSNatalya A. Shushunova
Natalya A. Shushunova